A plasma protein indistinguishable from ribosomal protein S19: Conversion to a monocyte chemotactic factor by a factor XIIIa-catalyzed reaction on activated platelet membrane phosphatidylserine in association with blood coagulation

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1542-1551

  Semba, Umeko ^a   Chen, Jun ^a   Ota, Yoshihiko ^a   Jia, Nan ^a   Arima, Hidetoshi ^a   Nishiura, Hiroshi ^a   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; COMPLEMENT COMPONENT C5A RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN; PHOSPHATIDYLSERINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA;

EID: 77749260621     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090720     Document Type: Article

References (29)

1. Yamamoto T: Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer. Pathol Internat 2000, 50:863-871
2. Yamamoto T: Roles of the ribosomal protein S19 dimer and the C5a receptor in pathophysiological functions of phagocytic leukocytes. Pathol Internat 2007, 57:1-11
3. Nishiura H, Tanase S, Shibuya Y, Nishimura T, Yamamoto T: Determination of the cross-linked residues in homo-dimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 1999, 79:915-923
4. Horino K, Nishiura H, Ohsako T, Shibuya Y, Hiraoka T, Kitamura N, Yamamoto T: A monocyte chemotactic factor. S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 1998, 78:603-617
5. Nishimura T, Horino K, Nishiura H, Shibuya Y, Hiraoka T, Tanase S, Yamamoto T: Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem 2001, 129:445-454
6. Nishiura H, Tanase S, Shibuya Y, Futa N, Sakamoto T, Higginbottom A, Monk P, Zwirner J, Yamamoto T: S19 ribosomal protein dimer augments metal-induced apoptosis in a mouse fibroblastic cell line by ligation of the C5a receptor. J Cell Biochem 2005, 94:540-553
7. Nishiura H, Shibuya Y, Matsubara S, Tanase S, Kambara T, Yamamoto T: Monocyte chemotactic factor in rheumatoid arthritis synovial tissue: probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 1996, 271:878-882
8. Shi L, Tsurusaki S, Futa N, Sakamoto T, Matsuda T, Nishino N, Kunitomo R, Kawasuji M, Tokita K, Yamamoto T: Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion. Virchow Archiv 2005, 447:747-755
9. Nishiura H, Shibuya Y, Yamamoto T: S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab Invest 1998, 78:1615-1623
10. Shrestha A, Horino K, Nishiura H, Yamamoto T: Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest 1999, 79:1629-1642
11. Oda Y, Tokita K, Ota Y, Li Y, Taniguchi K, Nishino N, Takagi K, Yamamoto T, Nishiura H: Agonistic and antagonistic effects of C5achimera bearing S19 ribosomal protein tail portion on the C5a receptor of monocytes and neutrophils, respectively. J Biochem 2008, 144:371-381
12. Kukita I, Yamamoto T, Kawaguchi T, Kambara T: Fifth component of complement (C5)-derived high molecular weight macrophage chemotactic factor in normal guinea pig serum. Inflammation 1987, 11:459-479
13. Okamoto M, Yamamoto T, Matsubara S, Kukita I, Takeya M, Miyauchi Y, Kambara T: Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. Biochim Biophys Acta 1992, 1138:53-61
14. Yamada D, Sekiya F, Morita T: Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism. J Biol Chem 1996, 271:5200-5207
15. Konteatis ZD, Siciliano SJ, Van-Riper G, Molineaux CJ, Pandya S, Fischer P, Rosen H, Mumford RA, Springer MS: Development of C5a receptor antagonists: differential loss of functional responses. J Immunol 1994, 153:4200 -4205
16. Shibuya Y, Shiokawa M, Nishiura H, Nishimura T, Nishino N, Okabe H, Takagi K, Yamamoto T: Identification of receptor binding sites of monocyte chemotactic S19 ribosomal protein dimer. Am J Pathol 2001, 159:2293-2301
17. Fernandez HN, Henson PM, Otani A, Hugli TE: Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin: polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Immunol 1978, 120:109-117
18. Matsubara S, Yamamoto T, Tsuruta T, Takagi K, Kambara T: Complement C4-derived monocyte-directed chemotaxis-inhibitory factor: a molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol 1991, 138:1279-1291
19. Falk W, Goldwin RH, Leonard EJ: A 48 well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980, 33:239-247
20. Cornwell DG, Kruger FA: Molecular complexes in the isolation and characterization of plasma lipoproteins. J Lipid Res 1961, 2: 110-134
21. Dittrich M, Birschmann I, Pfrang J, Herterich S, Smolenski A, Walter U, Dandekar T: Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost 2006, 95:643-651
22. Zimmerman GA, Weyrich AS: Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008, 28:s17-s24
23. Sahu SK, Gummadi SN, Manoj N, Aradhyam GK: Phospholipid scramblase: an overview. Archiv Biochem Biophys 2007, 462:103-114
24. Savill JS, Henson PM, Haslett C: Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "chargesensitive" recognition mechanism. J Clin Invest 1989, 84: 1518-1527
25. Quinn MT, Parthasarathy S, Steinberg D: Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 1988, 85:2805-2809
26. Jing Q, Xin SM, Zang WB, Wang P, Qin YW, Pei G: Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res 2000, 87:52-59
27. Davies MJ, Ballantine SJ, Robertson WB, Woolf N: The ultrastructure of organizing experimental mural thrombi in the pig aorta. J Pathol 1975, 117:75-81
28. Feigl W, Susani M, Ulrich W, Matejka M, Losert U, Sinzinger H: Organisation of experimental thrombosis by blood cells: evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells Virchows Arch 1985, 406:133-148
29. McGuinness CL, Humphries J, Waltham M, Burnand K, Collins GM, Smith A: Recruitment of labeled monocytes by experimental venous thrombi. Thromb Haemost 2001, 85:1018-1024